vs

Side-by-side financial comparison of Brookfield Renewable Partners L.P. (BEP) and CME Group (CME). Click either name above to swap in a different company.

CME Group is the larger business by last-quarter revenue ($1.9B vs $1.7B, roughly 1.1× Brookfield Renewable Partners L.P.). Brookfield Renewable Partners L.P. runs the higher net margin — 5.9% vs 0.1%, a 5.8% gap on every dollar of revenue. On growth, CME Group posted the faster year-over-year revenue change (14.5% vs 14.2%).

Brookfield Renewable Partners L.P. is a publicly traded limited partnership that owns and operates renewable power assets, with corporate headquarters in Toronto, Ontario, Canada. It is 60% owned by Brookfield Asset Management.

CME Group Inc. is an American financial services company based in Chicago, Illinois. It operates financial derivatives exchanges, including the Chicago Mercantile Exchange (CME), the Chicago Board of Trade (CBOT), the New York Mercantile Exchange (NYMEX), and the Commodity Exchange (COMEX). The company owns 27% of S&P Dow Jones Indices. It is the world's largest operator of financial derivatives exchanges. Its exchanges are platforms for trading in agricultural products, currencies, energy, i...

BEP vs CME — Head-to-Head

Bigger by revenue
CME
CME
1.1× larger
CME
$1.9B
$1.7B
BEP
Growing faster (revenue YoY)
CME
CME
+0.3% gap
CME
14.5%
14.2%
BEP
Higher net margin
BEP
BEP
5.8% more per $
BEP
5.9%
0.1%
CME

Income Statement — Q2 FY2025 vs Q1 FY2026

Metric
BEP
BEP
CME
CME
Revenue
$1.7B
$1.9B
Net Profit
$100.0M
$1.2M
Gross Margin
Operating Margin
0.1%
Net Margin
5.9%
0.1%
Revenue YoY
14.2%
14.5%
Net Profit YoY
213.6%
20.7%
EPS (diluted)
$-0.22

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
BEP
BEP
CME
CME
Q1 26
$1.9B
Q4 25
$1.6B
Q3 25
$1.5B
Q2 25
$1.7B
$1.7B
Q1 25
$1.6B
Q4 24
$1.5B
Q3 24
$1.6B
Q2 24
$1.5B
$1.5B
Net Profit
BEP
BEP
CME
CME
Q1 26
$1.2M
Q4 25
$1.2B
Q3 25
$908.0M
Q2 25
$100.0M
$1.0B
Q1 25
$956.2M
Q4 24
$874.6M
Q3 24
$912.8M
Q2 24
$-88.0M
$883.2M
Operating Margin
BEP
BEP
CME
CME
Q1 26
0.1%
Q4 25
61.8%
Q3 25
63.3%
Q2 25
66.7%
Q1 25
67.5%
Q4 24
62.1%
Q3 24
64.6%
Q2 24
65.3%
Net Margin
BEP
BEP
CME
CME
Q1 26
0.1%
Q4 25
71.7%
Q3 25
59.1%
Q2 25
5.9%
60.6%
Q1 25
58.2%
Q4 24
57.3%
Q3 24
57.6%
Q2 24
-5.9%
57.6%
EPS (diluted)
BEP
BEP
CME
CME
Q1 26
Q4 25
$3.24
Q3 25
$2.49
Q2 25
$-0.22
$2.81
Q1 25
$2.62
Q4 24
$2.40
Q3 24
$2.50
Q2 24
$-0.28
$2.42

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
BEP
BEP
CME
CME
Cash + ST InvestmentsLiquidity on hand
$1.9B
$2.4B
Total DebtLower is stronger
$3.4B
Stockholders' EquityBook value
$33.3B
Total Assets
$98.6B
$202.0B
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
BEP
BEP
CME
CME
Q1 26
$2.4B
Q4 25
$4.5B
Q3 25
$2.6B
Q2 25
$1.9B
$2.1B
Q1 25
$1.5B
Q4 24
$3.0B
Q3 24
$2.4B
Q2 24
$1.2B
$1.9B
Total Debt
BEP
BEP
CME
CME
Q1 26
$3.4B
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
Stockholders' Equity
BEP
BEP
CME
CME
Q1 26
Q4 25
$28.7B
Q3 25
$28.2B
Q2 25
$33.3B
$27.7B
Q1 25
$27.0B
Q4 24
$26.5B
Q3 24
$28.2B
Q2 24
$28.0B
$27.6B
Total Assets
BEP
BEP
CME
CME
Q1 26
$202.0B
Q4 25
$198.4B
Q3 25
$187.1B
Q2 25
$98.6B
$179.9B
Q1 25
$157.8B
Q4 24
$137.4B
Q3 24
$137.8B
Q2 24
$73.8B
$123.4B

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
BEP
BEP
CME
CME
Operating Cash FlowLast quarter
$379.0M
Free Cash FlowOCF − Capex
FCF MarginFCF / Revenue
Capex IntensityCapex / Revenue
Cash ConversionOCF / Net Profit
3.79×
TTM Free Cash FlowTrailing 4 quarters

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
BEP
BEP
CME
CME
Q1 26
Q4 25
$1.1B
Q3 25
$968.1M
Q2 25
$379.0M
$1.1B
Q1 25
$1.1B
Q4 24
$1.0B
Q3 24
$1.0B
Q2 24
$231.0M
$776.9M
Free Cash Flow
BEP
BEP
CME
CME
Q1 26
Q4 25
$1.1B
Q3 25
$949.7M
Q2 25
$1.0B
Q1 25
$1.1B
Q4 24
$991.7M
Q3 24
$973.2M
Q2 24
$758.7M
FCF Margin
BEP
BEP
CME
CME
Q1 26
Q4 25
66.8%
Q3 25
61.8%
Q2 25
61.5%
Q1 25
67.1%
Q4 24
65.0%
Q3 24
61.4%
Q2 24
49.5%
Capex Intensity
BEP
BEP
CME
CME
Q1 26
Q4 25
2.0%
Q3 25
1.2%
Q2 25
1.1%
Q1 25
0.9%
Q4 24
1.7%
Q3 24
1.9%
Q2 24
1.2%
Cash Conversion
BEP
BEP
CME
CME
Q1 26
Q4 25
0.96×
Q3 25
1.07×
Q2 25
3.79×
1.03×
Q1 25
1.17×
Q4 24
1.16×
Q3 24
1.10×
Q2 24
0.88×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons